ERBB2 and breast carcinoma: TNC− and TNC+ groups almost equally distributed between breast cancer subtypes except for Her2+ breast cancer specimens where the TNC+ phenotype was more prominent (41%) than the TNC− phenotype (29%) (Table 1).